	Metastatic renal cell carcinoma: risk of rapid progression to pathological fractures and factors influencing post-treatment survival - a Swedish Nationwide cohort study. J Bone Oncol Åkerstedt J, Åström T, Wennergren D, Wänman J. PMID: 41732251 [PubMed]
	Association between dose to specific pelvic substructures and urinary and sexual dysfunction following Single-Dose ablative radiotherapy for prostate Cancer: A post hoc analysis from the ABRUPT trial. Clin Transl Radiat Oncol Arcangeli S, Faccenda V, Ferrario F, Chissotti C, De Sanctis L, Rossano G, Arcieri E, Pisoni V, Colciago RR, De Ponti E, Panizza D. PMID: 41732214 [PubMed]
	Steroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial designs. Future Oncol Yu EY, Gratzke C, Burotto M, Zhang AY, Lévesque E, Ortega F, Peer A, Vile D, Chen ZH, Song Y, Schloss C, Todoric J, Garratt C, Poehlein C, Antonarakis ES, Fizazi K. PMID: 41732008 [PubMed - as supplied by publisher]
	Effect of Neoadjuvant Chemo-Hormonal Therapy on Reducing Recurrence in Patients With Very High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy. Int J Urol Koyama Y, Morizane S, Moriyasu E, Hoshino T, Yamamoto A, Omatsu R, Yamane H, Makishima K, Nishikawa R, Kimura Y, Yamaguchi N, Hikita K, Umekita Y, Takenaka A. PMID: 41731919 [PubMed - indexed for MEDLINE]
	A Dual-Hue Recognizable Lateral Flow Immunoassay Corresponding to Distinct Sensitivity Ranges for Timely and Quantitative Diagnosis of Prostate Cancer. ACS Nano Hu R, Zhang X, Huang L, Hu J, Wang J. PMID: 41730849 [PubMed - as supplied by publisher]
	Beyond Chronologic Age: Frailty, Geriatric Assessment, and Personalized Care for Older Adults With Genitourinary Cancer. Am Soc Clin Oncol Educ Book Lee PL, Fitch C, Efstathiou JA, Garg T. PMID: 41730161 [PubMed - indexed for MEDLINE]
	Survival study of cytoreductive prostatectomy for prostate cancer with lung metastasis: A propensity score matching study based on the SEER database. PLoS One Xiang AP, Yuan XF, Qin ZQ. PMID: 41729968 [PubMed - indexed for MEDLINE]
	Acquisition, image quality, and PI-RADS agreement of ultrahigh-gradient DWI in prostate 3-T MRI. Eur Radiol Exp Bischoff LM, Endler C, Krausewitz P, Ellinger J, Klümper N, Isaak A, Mesropyan N, Kravchenko D, Kuetting D, Sprinkart AM, Mürtz P, Pieper CC, Luetkens JA. PMID: 41729479 [PubMed - indexed for MEDLINE]
	A Dual-Threshold Strategy Enables Reliable Biopsy-Free Diagnosis of High-Risk Prostate Cancer. Prostate Liang Y, Chen Z, Zhang J, Liao Z, Zhang Z, Liu Y, Xu Z, Ma Y, Cheng C, Xie H, Niu S, Tao T. PMID: 41728744 [PubMed - as supplied by publisher]
	Artificial intelligence-assisted diagnosis and histopathological grading of bladder cancer: current status, challenges, and future directions. Front Digit Health Zhang L, Zhong Y, Yang G, Huang L, Deng A, Ao M, Li J. PMID: 41728380 [PubMed]
	Disparities in prostate cancer outcomes between First Nations and Non-First Nations men in Canada-Cohort study. Lancet Reg Health Am Albers P, Amin K, Broomfield S, Geary J, Pader J, Letendre A, Clark W, Colquhoun A, Bill L, Kinnaird A. PMID: 41728103 [PubMed]
	Incidental prostate cancer status in two tertiary centers in Kigali, Rwanda: insights from a retrospective review. Pan Afr Med J Ndayishimye T, Mutuyimana DJ, Ikugabire S, Mwizerwa JL, Byakagaba E, Ngendahayo E, Gasana AG, Muhawenimana E. PMID: 41727538 [PubMed - indexed for MEDLINE]
	High PVR protein expression marks clear cell renal cell carcinoma with metastatic spread. Front Immunol Ku, Bellulovich E, Golemac M, Jak, Marki, Mikli, Mali, Babarovi, , , Lisni, Tsukerman P, Cinamon G, Jonji, Lenac Rovi. PMID: 41727425 [PubMed - indexed for MEDLINE]
	Perineural Invasion in Radical Prostatectomy Specimens and Its Association with Biochemical Recurrence and Survival in Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Open Sci Karwacki J, Klasen K, Wojdy, Kaczorowski M, Gurwin A, Ha, Rajwa P, Zattoni F, Baboudjian M, Yanagisawa T, Patrza, Krajewski W, Szyde, Ma. PMID: 41726852 [PubMed]
	Development and validation of a combined diagnostic model for prostate cancer integrating MRI parameters with p504s, CK5/6, and Ki-67 expression. Open Life Sci Ren Q, Gu J, Lu N. PMID: 41726553 [PubMed]
	Evaluating [(18)F]-DCFPyL for Detecting Prostate Cancer Recurrence: A Cost-Consequence Comparison with Alternative PET Radiotracers in Spain. J Mark Access Health Policy Matos T, Godbole M, Badinedi R, Muthukumar M, Hodolic M, Tchouen N, Berthon A. PMID: 41726119 [PubMed]
	Clinical Characteristics and Management of Two Cases of Complete Androgen Insensitivity Syndrome With Germ Cell Tumors. Cancer Rep (Hoboken) Wang F, Wang D, Li J, Xing N. PMID: 41725111 [PubMed - indexed for MEDLINE]
	Cell-of-origin and genetic drivers define advanced bladder cancer subtypes and potential therapeutic response in mouse models. J Exp Clin Cancer Res Munera-Maravilla E, Pérez-Escavy M, Rubio C, Segovia C, Lodewijk I, Nunes SP, Martín de Bernardo Á, A Reina I, Montesinos E, Morales L, Martínez VG, Álvarez-Prada A, Martínez-Fernández M, Dueñas M, Paramio JM, Suárez-Cabrera C. PMID: 41724981 [PubMed - as supplied by publisher]
	Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group. Eur Urol Gupta S, Li R, Hensley PJ, Daneshmand S, Faltas BM, Grivas P, Lobo N, Mir MC, Meeks JJ, Mouw KW, Moschini M, Necchi A, Oualla K, Pohar KS, Rosenberg JE, Schmidt B, Siefker-Radtke AO, Steinberg GD, Stenzl A, Buckley RJ, Kamat AM. PMID: 41724648 [PubMed - as supplied by publisher]
	Reply to Armando Stabile, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Jianliang Liu, Laurence Harewood, Dominic Bagguley, et al. Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer. Eur Urol Oncol 2025;8:1118-25. Eur Urol Oncol Liu J, Chengodu T, Ryan A, Sim K, Wang W, Sheldon J, Lawrentschuk N. PMID: 41724635 [PubMed - as supplied by publisher]

Articles 1 - 20 / 176242

Page 1 of 8813



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy